Found 4355 articles for: ""
Factors Impacting New Drug Adoption in the Clinical Setting: A Survey of Dermatologists
January 2024 | Volume 23 | Issue 1 | Editorials | 1362 | Copyright © January 2024
The 200-Year Timeline on Botulinum Toxin: From Biologic Poison to Wonder Drug
January 2024 | Volume 23 | Issue 1 | Features | 1357 | Copyright © January 2024
The history of botulinum toxin dates back to the late 1700s, when food preparation, storage, and later canning practices led to outbreaks of botulism across Europe and the United States. It is fr...
Read MorePost-Hyaluronic Acid Filler Reaction Treated With Abrocitinib: A Case Report
January 2024 | Volume 23 | Issue 1 | Case Reports | 1355 | Copyright © January 2024
Post-hyaluronic acid filler nodules are uncommon, unpredictable complications that present a challenge to clinical therapy. We report a case of a female in her fifties who developed edema and nod...
Read MoreThe Importance of Photoaging Prevention in All Skin Types: An Update on Current Advancements
January 2024 | Volume 23 | Issue 1 | Original Article | 1306 | Copyright © January 2024
Light from across the electromagnetic spectrum, including ultraviolet, visible, and infrared light, can cause detrimental cutaneous effects including photocarcinogenesis and photoaging. Tradition...
Read MoreOral Minoxidil Media Coverage: The Impact on Patient Perceptions and Practitioner Approaches to Androgenetic Alopecia
January 2024 | Volume 23 | Issue 1 | Editorials | 1364 | Copyright © January 2024
Deucravacitinib for Moderate-to-Severe Psoriasis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
February 2024 | Volume 23 | Issue 2 | Original Article | 67 | Copyright © February 2024
There is contrasting evidence regarding the efficacy and safety of JAK (Janus kinase) inhibitors in the treatment of psoriasis. This systematic review and meta-analysis assessed deucravacitinib, ...
Read MoreDo the Words We Choose Matter When Prescribing Medications?
December 2023 | Volume 22 | Issue 12 | Original Article | 1216 | Copyright © December 2023
Background: Caregivers are often apprehensive about treating childhood atopic dermatitis (AD) with topical corticosteroids but may find comfort if treatments are presented in a p...
Read MoreA Single-Center, Observational Experience With a Bovine Collagen Wound Dressing for Distal Lower Extremity Surgical Defects
December 2023 | Volume 22 | Issue 12 | Original Article | 1149 | Copyright © December 2023
Background: Biologic dressings help treat many dermatologic conditions. Their use in dermatologic surgery continues to expand as new dressings are developed....
Read MoreA Case Series of Patients With Eczematous Eruptions Following IL-17 Inhibitor Treatment for Psoriasis Vulgaris
December 2023 | Volume 22 | Issue 12 | Case Reports | 1225 | Copyright © December 2023
Psoriasis vulgaris and eczema are characterized by an imbalance in the Th1 and Th2 immune response and distinct cytokine profiles, where Th1 is more prominent in psoriasis and Th2 is more promine...
Read MoreIntralesional Sodium Thiosulfate as Adjuvant Therapy in Severe Calciphylaxis
December 2023 | Volume 22 | Issue 12 | Case Reports | e28 | Copyright © December 2023
Calciphylaxis is a rare disease characterized by calcification of the middle layer of small arteries and arterioles, causing secondary cuta-neous ischemia. The diagnosis is clinical but may be co...
Read MoreSuccessful Treatment of Keloids and Hypertrophic Scars With Systemic and Intralesional Dupilumab
December 2023 | Volume 22 | Issue 12 | Case Reports | 1220 | Copyright © December 2023
Keloids and hypertrophic scars negatively impact the quality of life for millions of people in the world. Unfortunately, though many thera-peutic approaches are used to treat scars, they are ofte...
Read MoreOff-Label Use of Janus Kinase Inhibitors in Inflammatory Cutaneous Diseases
December 2023 | Volume 22 | Issue 12 | Original Article | 1183 | Copyright © December 2023
Dysregulation of Janus kinase (JAK) pathways from uncontrolled cytokine signaling comprises the pathological basis for many complex inflammatory cutaneous disorders. Oral JAK inhibitors, upadacit...
Read MoreA Salicylic Acid-Based Dermocosmetic is Effective as an Adjunct to Benzoyl Peroxide for Mild to Moderate Acne and as Monotherapy in Maintenance Post Benzoyl Peroxide
December 2023 | Volume 22 | Issue 12 | Original Article | 1172 | Copyright © December 2023
Background: A dermocosmetic (DC) containing salicylic acid, niacinamide, and thermal spring water has been developed for the management of mild to moderate acne.Read More Cryosurgery and 5-Fluorouracil Combination Therapy for Treatment of Bowen's Disease and Superficial Basal Cell Carcinoma
December 2023 | Volume 22 | Issue 12 | Original Article | 1166 | Copyright © December 2023
Background: Non-melanoma skin cancer (NMSC), which includes both Bowen's disease (BD) and superficial basal cell carcinoma (sBCC), is the most commonly diagnosed cancer in Canada...
Read MoreFULL SUPPLEMENT: Prurigo Nodularis
December 2023 | Volume 22 | Issue 12 | Department | SF365502s1 | Copyright © December 2023
Prurigo nodularis (PN) was first accurately described more than a century ago by Hyde and Montgomery as chronic itchy nodules commonly noted in symmetric distribution on extensor sites of limbs, upper...
Read MoreINDIVIDUAL ARTICLE: Management of Prurigo Nodularis
December 2023 | Volume 22 | Issue 12 | Supplement Individual Articles | SF365502s15 | Copyright © December 2023
Background: Prurigo nodularis (PN) is a chronic disease characterized by intense pruritus and nodular lesions associated with reduced quality of life. Until recently, no US Food ...
Read MoreINDIVIDUAL ARTICLE: Patient Journey and the Burden of Systemic Comorbidities and Sequalae in Prurigo Nodularis
December 2023 | Volume 22 | Issue 12 | Supplement Individual Articles | SF365502s12 | Copyright © December 2023
Background: Prurigo Nodularis (PN) is a relatively rare chronic inflammatory skin disease characterized by firm pruritic nodules. PN is associated with significantly increased ra...
Read MoreINDIVIDUAL ARTICLE: Prurigo Nodularis: Current Clinicopathologic Overview and Psychodermatological Perspectives
December 2023 | Volume 22 | Issue 12 | Supplement Individual Articles | SF365502s6 | Copyright © December 2023
Prurigo nodularis (PN) is a quintessential neurocutaneous condition characterized by neural sensitization and intractable itch leading to intense scratching. This causes the formation of nodules ...
Read MoreINDIVIDUAL ARTICLE: New Horizons in Our Understanding of Prurigo Nodularis and Its Management
December 2023 | Volume 22 | Issue 12 | Supplement Individual Articles | SF365502s4 | Copyright © December 2023
FULL SUPPLEMENT: Real-World Experience Integrating Ceramide-Containing Cleansers And Moisturizers Into Prescription Treatment and Maintenance for Pediatric Patients With Atopic Dermatitis
December 2023 | Volume 22 | Issue 12 | Department | SF389716s2 | Copyright © December 2023
Introduction: Atopic dermatitis (AD) is a common, chronic recurrent disorder typically starting in infancy and early childhood and associated with pruritus and genetic predisposition....
Read MoreMedia and other results for: ""